Search research articles
Contact Us
Filters
Showing results (81-90 of 105) with videos related to
Page
of 11
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 29, 2018
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases
Erwin Dreesen, Bram Verstockt, Sumin Bian, et al.
Drugs & Aging
|
August 19, 2024
Decreased Kidney Function Explains Higher Vancomycin Exposure in Older Adults
Angela Elma Edwina, Erwin Dreesen, Matthias Gijsen, et al.
International Journal of Pharmaceutics
|
December 7, 2024
Tracking the journey: Gastrointestinal transit and intraluminal pH dynamics in aging populations using wireless motility capsule
Angela Elma Edwina, Mirko Koziolek, Nele Steenackers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 9, 2025
Infliximab and Ustekinumab Clearance Better Predict Endoscopic Outcomes Than Trough Concentrations in Crohn's Disease
Zhigang Wang, Yannick Hoffert, Wei Zhang, et al.
Journal of Crohn'S & Colitis
|
February 5, 2019
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates
Bram Verstockt, Erwin Dreesen, Maja Noman, et al.
Clinical and Translational Science
|
June 19, 2026
European Network on Optimizing Treatment With Therapeutic Antibodies in Chronic Inflammatory Diseases: Overview, Progress and Perspectives
Konstantin Tachkov, Merita Rumano, James Bluett, et al.
Pediatric Research
|
October 11, 2024
Human serum albumin: prediction model and reference values for preterm and term neonates
Zoë Vander Elst, Annouschka Laenen, Jana Deberdt, et al.
Mycoses
|
May 8, 2021
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics
Ruth Van Daele, Yves Debaveye, Robin Vos, et al.
Mycoses
|
April 19, 2022
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study
Ruth Van Daele, Joost Wauters, Erwin Dreesen, et al.
The Journal of Antimicrobial Chemotherapy
|
January 31, 2021
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation
Ruth Van Daele, Roger J Brüggemann, Erwin Dreesen, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 105) with videos related to
Sort By:
Page
of 11
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 29, 2018
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases
Erwin Dreesen, Bram Verstockt, Sumin Bian, et al.
Drugs & Aging
|
August 19, 2024
Decreased Kidney Function Explains Higher Vancomycin Exposure in Older Adults
Angela Elma Edwina, Erwin Dreesen, Matthias Gijsen, et al.
International Journal of Pharmaceutics
|
December 7, 2024
Tracking the journey: Gastrointestinal transit and intraluminal pH dynamics in aging populations using wireless motility capsule
Angela Elma Edwina, Mirko Koziolek, Nele Steenackers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 9, 2025
Infliximab and Ustekinumab Clearance Better Predict Endoscopic Outcomes Than Trough Concentrations in Crohn's Disease
Zhigang Wang, Yannick Hoffert, Wei Zhang, et al.
Journal of Crohn'S & Colitis
|
February 5, 2019
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates
Bram Verstockt, Erwin Dreesen, Maja Noman, et al.
Clinical and Translational Science
|
June 19, 2026
European Network on Optimizing Treatment With Therapeutic Antibodies in Chronic Inflammatory Diseases: Overview, Progress and Perspectives
Konstantin Tachkov, Merita Rumano, James Bluett, et al.
Pediatric Research
|
October 11, 2024
Human serum albumin: prediction model and reference values for preterm and term neonates
Zoë Vander Elst, Annouschka Laenen, Jana Deberdt, et al.
Mycoses
|
May 8, 2021
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics
Ruth Van Daele, Yves Debaveye, Robin Vos, et al.
Mycoses
|
April 19, 2022
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study
Ruth Van Daele, Joost Wauters, Erwin Dreesen, et al.
The Journal of Antimicrobial Chemotherapy
|
January 31, 2021
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation
Ruth Van Daele, Roger J Brüggemann, Erwin Dreesen, et al.
Page
of 11